Hypertension Induced by St. John’s Wort

D. Zullino; F. Borgeat

doi:10.1055/s-2003-38086

Pharmacopsychiatry, Inhaltsverzeichnis

Pharmacopsychiatry 2003; 36(1): 32
DOI: 10.1055/s-2003-38086

Letter

Hypertension Induced by St. John’s Wort

A Case ReportD. Zullino¹ , F. Borgeat²

¹Unité de Biochemie et Psychopharmacologie Clinique, Départment Universitaire de Psychiatrie Adulte, Prilly - Lausanne, Switzerland
²Départment Universitaire de Psychiatrie Adulte, Prilly - Lausanne, Switzerland

From the AMSP drug safety program (Arzneimittelsicherheit in der Psychiatrie): case LAU-01-027

Abstract

Volltext

Referenzen

References

1 Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E. Effect of acute administration of hypericum perforatum-CO₂ extract on dopamine and serotonin release in the rat central nervous system. Pharmacopsychiat. 2000; 33 14-18
2 Grohmann R, Rüther E, Engel R R, Hippius H. Assessment of adverse drug reactions in psychiatric in patients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiat. 1999; 32 21-28
3 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiat. 1998; 31 16-21
4 Thase M E. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry. 1998; 59 502-508

Daniele Zullino,MD

Unité de Biochemie et Psychopharmacologie Clinique

Département Universitaire de Psychiatrie Adulte

Clinique de Cery

CH-1008 Prilly - Lausanne

Telefon: +41-21-643-64-04

Fax: +41-21-643-64-44

eMail: Daniele.Zullino@inst.hospvd.ch